These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 6313195

  • 1. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL.
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [Abstract] [Full Text] [Related]

  • 2. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
    Rouhan D, Le Noc P, Le Noc D.
    Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
    [Abstract] [Full Text] [Related]

  • 3. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R, Gutmann L, Kitzis MD, Goldstein F, Acar JF.
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [Abstract] [Full Text] [Related]

  • 4. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA, Day GJ, Humble MW.
    N Z Med J; 1982 Jun 23; 95(710):414-6. PubMed ID: 6810246
    [Abstract] [Full Text] [Related]

  • 5. Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.
    Jacobus NV, Tally FP, Barza M, Gorbach SL.
    Clin Ther; 1980 Jun 23; 3(Spec Issue):34-8. PubMed ID: 6446396
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M, Grehn M, Wundt W.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun 23; 252(2):208-21. PubMed ID: 6289564
    [Abstract] [Full Text] [Related]

  • 7. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P, Bryskier A, Le Noc D.
    Pathol Biol (Paris); 1983 May 23; 31(5):351-6. PubMed ID: 6312396
    [Abstract] [Full Text] [Related]

  • 8. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L, Le Van Thoi J, Soussy CJ, Duval J.
    Pathol Biol (Paris); 1982 Jun 23; 30(6):363-9. PubMed ID: 6810282
    [Abstract] [Full Text] [Related]

  • 9. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT, Prignano G, Iegri F, Lorenzi A.
    Boll Ist Sieroter Milan; 1982 Jun 23; 61(4):309-19. PubMed ID: 6100234
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activities of third-generation cephalosporins.
    Fass RJ.
    Arch Intern Med; 1983 Sep 23; 143(9):1743-5. PubMed ID: 6615095
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
    Appelbaum PC, Tamim J, Pankuch GA, Aber RC.
    Chemotherapy; 1983 Sep 23; 29(5):337-44. PubMed ID: 6311492
    [Abstract] [Full Text] [Related]

  • 12. Comparative in vitro activity of first, second and third generation cephalosporins.
    Forsgren A.
    Acta Pathol Microbiol Scand B; 1981 Aug 23; 89(4):221-5. PubMed ID: 6274143
    [Abstract] [Full Text] [Related]

  • 13. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
    Carlone NA, Cuffini AM, Forno-Pizzoglio M, Aragno M.
    G Batteriol Virol Immunol; 1983 Aug 23; 76(7-12):246-56. PubMed ID: 6099297
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
    Esposito S, Galante D, Barba D.
    Chemioterapia; 1986 Apr 23; 5(2):101-4. PubMed ID: 3518963
    [Abstract] [Full Text] [Related]

  • 15. Third-generation cephalosporins: a critical evaluation.
    Barriere SL, Flaherty JF.
    Clin Pharm; 1984 Apr 23; 3(4):351-73. PubMed ID: 6432420
    [Abstract] [Full Text] [Related]

  • 16. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan 23; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 17. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I, Warren C, Shannon K, King A, Hanslo D.
    J Antimicrob Chemother; 1981 Sep 23; 8 Suppl B():23-31. PubMed ID: 19802967
    [Abstract] [Full Text] [Related]

  • 18. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
    Ravizzola G, Bonfanti C, Savoldi E, Turano A.
    Chemioterapia; 1985 Jun 23; 4(3):204-8. PubMed ID: 3875430
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin.
    Bremner DA.
    Chemotherapy; 1983 Jun 23; 29(4):283-8. PubMed ID: 6307605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.